XFNT:XETRA:XETRA-Xtrackers MSCI Fintech Innovation UCITS ETF 1C USD Acc (EUR)

ETF | Others |

Last Closing

USD 36.465

Change

+0.01 (+0.01)%

Market Cap

USD 7.71M

Volume

1.38K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.89 (+1.72%)

USD 548.90B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.30 (+1.80%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.43 (+1.60%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.48 (+1.69%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.40 (+1.62%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+2.86 (+1.90%)

USD 103.20B
JARI:XETRA Amundi Index Solutions - Amund..

+0.67 (+1.49%)

USD 102.92B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.90 (+1.74%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+0.84 (+0.15%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.36 (+1.58%)

USD 79.79B

ETFs Containing XFNT:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.80% 86% B+ 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.80% 86% B+ 84% B
Trailing 12 Months  
Capital Gain 26.68% 84% B 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.68% 84% B 82% B
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 8.80% 70% C- 68% D+
Dividend Return 8.80% 69% C- 65% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.23% 50% F 60% D-
Risk Adjusted Return 71.99% 80% B- 82% B
Market Capitalization 7.71M 7% C- 6% D-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.